Tumour therapy with radionuclides: assessment of progress and problems
- 1 February 2003
- journal article
- review article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 66 (2) , 107-117
- https://doi.org/10.1016/s0167-8140(02)00374-2
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Radioimmunotherapy of small-volume disease of metastatic colorectal cancerCancer, 2002
- High-Dose Samarium-153 Ethylene Diamine Tetramethylene Phosphonate: Low Toxicity of Skeletal Irradiation in Patients With Osteosarcoma and Bone MetastasesJournal of Clinical Oncology, 2002
- Growth factors and their receptors: new targets for prostate cancer therapyUrology, 2001
- Biodistribution, Blood Half-Life, and Receptor Binding of a Somatostatin-Dextran ConjugateMedical Oncology, 2001
- Low-energy Electron Emitters for Targeted Radiotherapy of Small TumoursActa Oncologica, 2001
- The molecular biology of cancerMolecular Aspects of Medicine, 2000
- Dosimetry and dose–response relationships in newly diagnosed patients with malignant gliomas treated with Iodine-131-Labeled anti-tenascin monoclonal antibody 81C6 therapyInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Generating improved single-chain Fv molecules for tumor targetingJournal of Immunological Methods, 1999
- Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations.European Journal of Nuclear Medicine and Molecular Imaging, 1998
- Increased level of c-erbB-2/neu/HER-2 protein in cutaneous squamous cell carcinomaBritish Journal of Dermatology, 1997